Indonesia to Bring in Doctors from Belarus for Specialist Training
The Ministry of Health will bring in doctors from Belarus to train medical professionals in Indonesia. The plan was agreed during a bilateral meeting between Deputy Minister of Health Dante Saksono Habuwono and Belarusian Minister of Health Aliaksandr Khajayeu at the Prof. Dr. dr. Mahar Mardjono National Brain Centre Hospital in Jakarta on Wednesday, 1 July 2026. Dante stated that cooperation with Belarus will focus on developing medical education and the pharmaceutical sector. In education, Indonesia is exploring a fellowship programme to improve the competence of doctors in several specialist fields. “We will send a delegation to Belarus to evaluate programmes there, as well as bring Belarusian doctors to Indonesia to provide training for our doctors,” Dante said, as quoted from the Ministry of Health website on Saturday, 4 July 2026. According to Dante, the training programme will focus on the treatment of heart disease, cancer, neurology and stroke, urology, nephrology, and maternal and child health. He assessed that Belarus has experience that can complement the development of Indonesia’s health system. In addition, the two countries, which have had bilateral relations for 33 years, will also cooperate in the pharmaceutical sector. The Indonesian government is opening opportunities for collaboration between the Belarusian pharmaceutical company Belpharmprom and domestic manufacturing industries to expand access and distribution of medical devices and pharmaceutical products. “Tomorrow morning, pharmaceutical companies from Indonesia will hold a meeting with their counterparts. The Ministry of Health fully supports this development and will facilitate coordination with Belarusian pharmaceutical companies,” Dante said. Meanwhile, Belarusian Minister of Health Aliaksandr Khajayeu said that Indonesia and Belarus share many similarities in regulating the use of generic medicines. This similarity is expected to accelerate the implementation of joint programmes. “Regarding the areas of cooperation, this has been a very good meeting. Our standards, especially for generic medicines, do not have significant differences. We are ready to welcome specialists directly to accelerate the process,” Aliaksandr said. As a follow-up to the agreement, the Ministry of Health stated that it has drafted an Operational Road Map 2026–2030 as an operational instrument for the high-level agreement. This roadmap is designed to ensure that various programmes, including the exchange of experts, medical education, and pharmaceutical collaboration, can proceed measurably and provide benefits for the health systems of both countries.